<DOC>
	<DOCNO>NCT00000613</DOCNO>
	<brief_summary>To determine acceptability benefit use dietary supplement phytoestrogen , genistein , versus placebo heart disease risk factor , bone density , psychosocial outcome postmenopausal woman .</brief_summary>
	<brief_title>CVD Risk Health Postmenopausal Phytoestrogen Users</brief_title>
	<detailed_description>BACKGROUND : Estrogen replacement therapy beneficial heart disease risk factor well bone density . However , large proportion postmenopausal woman compliant therapeutic regimen . Phytoestrogens naturally occur compound find plant soy product estrogenic effect , may represent alternative treatment prevention heart disease osteoporosis postmenopausal woman . However , intervention trial examine extent possible improve heart disease risk factor , bone density , quality life postmenopausal woman use dietary supplement phytoestrogen . DESIGN NARRATIVE : Randomized , double-blind , placebo-controlled study . A total 210 woman enrol study follow one two year . The woman randomize phytoestrogen treatment placebo . Data collect baseline visit , one three month follow-up telephone call , 6 , 12 , 24 month follow-up clinic visit . Measures high density lipoprotein heart disease risk factor , hip spine bone density , depression , life satisfaction , quality well-being obtain . Cross-sectional longitudinal comparison treatment placebo group perform adjustment stratification potentially confound covariates . The study renew March 2002 ass whether woman treat phytoestrogens lower homocysteine , interleukin-6 , C-reactive protein , E-selectin , decrease obesity fat mass two year . The study completion date list record obtain `` End Date '' enter Protocol Registration Results System ( PRS ) record .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Bone Diseases</mesh_term>
	<mesh_term>Genistein</mesh_term>
	<criteria>Postmenopausal woman , age 45 74 .</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>December 2005</verification_date>
</DOC>